These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30255329)

  • 1. Is neoadjuvant chemotherapy appropriate for patients with resectable liver metastases from colorectal cancer?
    Hirokawa F; Asakuma M; Komeda K; Shimizu T; Inoue Y; Kagota S; Tomioka A; Uchiyama K
    Surg Today; 2019 Jan; 49(1):82-89. PubMed ID: 30255329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant Chemotherapy Versus Upfront Surgery for Resectable Liver Metastases from Colorectal Cancer: a Multicenter, Propensity Score-Matched Cohort Study.
    Hirokawa F; Ueno M; Nakai T; Kaibori M; Nomi T; Iida H; Tanaka S; Komeda K; Hayami S; Kosaka H; Hokuto D; Kubo S; Uchiyama K
    J Gastrointest Surg; 2022 Apr; 26(4):772-781. PubMed ID: 34664190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of neoadjuvant chemotherapy in patients with high-risk resectable colorectal liver metastases.
    Ninomiya M; Emi Y; Motomura T; Tomino T; Iguchi T; Kayashima H; Harada N; Uchiyama H; Nishizaki T; Higashi H; Kuwano H
    Int J Clin Oncol; 2021 Dec; 26(12):2255-2264. PubMed ID: 34519930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of upfront hepatectomy without neoadjuvant chemotherapy for resectable colorectal liver metastasis.
    Ono K; Abe T; Oshita A; Sumi Y; Yano T; Okuda H; Kurayoshi M; Kobayashi T; Ohdan H; Noriyuki T; Nakahara M
    World J Surg Oncol; 2021 Apr; 19(1):97. PubMed ID: 33820549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score.
    Yonekawa Y; Uehara K; Mizuno T; Aiba T; Ogura A; Mukai T; Yokoyama Y; Ebata T; Kodera Y; Nagino M
    Int J Clin Oncol; 2021 Jan; 26(1):126-134. PubMed ID: 33074351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant chemotherapy versus upfront surgery as the initial treatment for patients with resectable, synchronous colorectal cancer liver metastases.
    Lee JM; Han YD; Cho MS; Hur H; Lee KY; Kim NK; Min BS
    J Surg Oncol; 2023 Sep; 128(4):549-559. PubMed ID: 37288777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases.
    Ichida H; Mise Y; Ito H; Ishizawa T; Inoue Y; Takahashi Y; Shinozaki E; Yamaguchi K; Saiura A
    World J Surg Oncol; 2019 Jun; 17(1):100. PubMed ID: 31196104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reconsideration of the indications for adjuvant chemotherapy for liver metastases from colorectal cancer after initial hepatectomy.
    Hirokawa F; Hayashi M; Miyamoto Y; Asakuma M; Shimizu T; Komeda K; Inoue Y; Uchiyama K
    Ann Surg Oncol; 2014 Jan; 21(1):139-46. PubMed ID: 24121880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative adjuvant chemotherapy is important for improving long-term survival in patients with colorectal cancer liver metastases undergoing simultaneous resection.
    Zhong W; Xu B; Lu Y; Chang J; Xu L; Zhao H; Che X
    J Gastroenterol Hepatol; 2024 May; 39(5):908-919. PubMed ID: 38323685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognosis of liver resection for patients with four or more colorectal liver metastases has not improved in the era of modern chemotherapy.
    Hokuto D; Nomi T; Yamato I; Yasuda S; Obara S; Yoshikawa T; Kawaguchi C; Yamada T; Kanehiro H; Nakajima Y
    J Surg Oncol; 2016 Dec; 114(8):959-965. PubMed ID: 27683191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Neoadjuvant Chemotherapy in Patients with Colorectal Cancer Liver Metastases.
    Sui K; Okabayashi T; Iwata J; Morita SM; Matsumoto T; Inada R; Iiyama T; Shimada Y; Kobayashi M
    Surg Technol Int; 2019 May; 34():208-214. PubMed ID: 31037714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoadjuvant chemotherapy for borderline resectable colorectal cancer liver metastases: a single-institution retrospective study.
    Kitano Y; Ono Y; Kobayashi K; Oba A; Sato T; Ito H; Inoue Y; Shinozaki E; Yamaguchi K; Saiura A; Baba H; Takahashi Y
    HPB (Oxford); 2024 Feb; 26(2):282-290. PubMed ID: 37985325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors for Unresectable Recurrence After Up-Front Surgery for Colorectal Liver Metastasis.
    Hokuto D; Nomi T; Yasuda S; Yoshikawa T; Ishioka K; Yamada T; Akahori T; Nakagawa K; Nagai M; Nakamura K; Obara S; Kanehiro H; Sho M
    World J Surg; 2018 Mar; 42(3):884-891. PubMed ID: 28879511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CALy Prognostic Score (CEA, ALP, Lymphocyte Count) as a predictor of survival after hepatectomy for liver-only colorectal metastases.
    Neofytou K; Giakoustidis A; Mudan S
    J BUON; 2015; 20(3):746-55. PubMed ID: 26214626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy.
    Nakatani M; Migita K; Matsumoto S; Wakatsuki K; Ito M; Nakade H; Kunishige T; Kitano M; Kanehiro H
    Dis Esophagus; 2017 Aug; 30(8):1-7. PubMed ID: 28575242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic value of the primary tumor’s nodal status after surgery for colorectal liver metastases in the era of effective systemic therapy.
    van der Stok EP; Grünhagen DJ; Alberda WJ; Reitsma M; Rothbarth J; Verhoef C
    Dig Surg; 2015; 32(3):208-16. PubMed ID: 25896431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative chemotherapy in upfront resectable colorectal liver metastases: New elements for an old dilemma?
    Bernardi L; Roesel R; Aghayan DL; Majno-Hurst PE; De Dosso S; Cristaudi A
    Cancer Treat Rev; 2024 Mar; 124():102696. PubMed ID: 38335813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores-- A retrospective, propensity score matching analysis.
    Chen FL; Wang YY; Liu W; Xing BC
    Front Oncol; 2022; 12():973418. PubMed ID: 36132151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preoperative chemotherapy in the surgical treatment of colorectal liver metastases].
    Dede K; Láng I; Pörneczi B; Mester G; Fekete A; Kőszegi G; Mersich T; Besznyák I; Bursics A
    Magy Seb; 2013 Dec; 66(6):325-30. PubMed ID: 24333977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of systemic adjuvant, neoadjuvant and perioperative chemotherapy for resectable colorectal-liver metastases.
    Khoo E; O'Neill S; Brown E; Wigmore SJ; Harrison EM
    HPB (Oxford); 2016 Jun; 18(6):485-93. PubMed ID: 27317952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.